SCHEMBL1052115

SCHEMBL1052115

BrCCCc1ncc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL16167399 0.98 TBXAS1 (0.51)
SCHEMBL1738515 0.94 TBXAS1 (0.56)
SCHEMBL1999912 0.86
SCHEMBL3431746 0.86 TBXAS1 (0.66)
SCHEMBL9777191 0.86 TBXAS1 (0.60)
Bromide SCHEMBL10788284 0.84
SCHEMBL28062565 0.84 TBXAS1 (0.69)
SCHEMBL503743 0.84 TBXAS1 (0.69)
SCHEMBL27220899 0.83 TBXAS1 (0.53)
SCHEMBL285224 0.81 TERT (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113578380-B Column [5] arene ionic liquid catalyst based on propylimidazole functionalization and preparation method thereof 抚顺东科新能源科技有限公司 2022-07-22 CN disclosed
CN-113215400-B Method for extracting metal ions by using ionic liquid compound 苏州科技大学 2022-04-15 CN disclosed
CN-113578380-A Column [5] arene ionic liquid catalyst based on propylimidazole functionalization and preparation method thereof 辽宁东科药业有限公司 2021-11-02 CN disclosed
EP-2448926-A1 FLAVIN DERIVATIVES Biorelix, Inc. (US) 2012-05-09 EP disclosed
WO-2011008247-A1 FLAVIN DERIVATIVES BIORELIX, INC. (US) 2011-01-20 WO disclosed
EP-0604409-A4 COMPOSITIONS AND METHODS FOR DETECTING AND MODULATING RNA ACTIVITY AND GENE EXPRESSION. ISIS PHARMACEUTICALS INC (US) 1996-06-12 EP disclosed
EP-0604409-A1 COMPOSITIONS AND METHODS FOR DETECTING AND MODULATING RNA ACTIVITY AND GENE EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 1994-07-06 EP disclosed
WO-1991010671-A1 COMPOSITIONS AND METHODS FOR DETECTING AND MODULATING RNA ACTIVITY AND GENE EXPRESSION ISIS PHARMACEUTICALS, INC. (US) 1991-07-25 WO disclosed